These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23154565)

  • 1. First case of combined small-cell lung cancer with adenocarcinoma harboring EML4-ALK fusion and an exon 19 EGFR mutation in each histological component.
    Toyokawa G; Taguchi K; Ohba T; Morodomi Y; Takenaka T; Hirai F; Yamaguchi M; Seto T; Takenoyama M; Sugio K; Ichinose Y
    J Thorac Oncol; 2012 Dec; 7(12):e39-e41. PubMed ID: 23154565
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations.
    Shaozhang Z; Xiaomei L; Aiping Z; Jianbo H; Xiangqun S; Qitao Y
    Genes Chromosomes Cancer; 2012 Oct; 51(10):925-32. PubMed ID: 22736493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with wild-type EGFR.
    Wu SG; Kuo YW; Chang YL; Shih JY; Chen YH; Tsai MF; Yu CJ; Yang CH; Yang PC
    J Thorac Oncol; 2012 Jan; 7(1):98-104. PubMed ID: 22124476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].
    Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of lung adenocarcinoma harboring exon 19 EGFR deletion and EML4-ALK fusion gene.
    Chen X; Zhang J; Hu Q; Li X; Zhou C
    Lung Cancer; 2013 Aug; 81(2):308-10. PubMed ID: 23731739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene.
    Takahashi T; Sonobe M; Kobayashi M; Yoshizawa A; Menju T; Nakayama E; Mino N; Iwakiri S; Sato K; Miyahara R; Okubo K; Manabe T; Date H
    Ann Surg Oncol; 2010 Mar; 17(3):889-97. PubMed ID: 20183914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene.
    Tanaka H; Hayashi A; Morimoto T; Taima K; Tanaka Y; Shimada M; Kurose A; Takanashi S; Okumura K
    BMC Cancer; 2012 Nov; 12():558. PubMed ID: 23181703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent EML4-ALK-associated lung adenocarcinoma with a slow clinical course.
    Murakami S; Yokose T; Saito H; Sakuma Y; Matsukuma S; Hasegawa C; Kondo T; Oshita F; Ito H; Tsuboi M; Nakayama H; Kameda Y; Noda K; Yamada K
    Lung Cancer; 2010 Sep; 69(3):361-4. PubMed ID: 20659620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second Primary Lung Adenocarcinoma Harboring EML4-ALK After Surgically Resected EGFR Positive Lung Adenocarcinoma.
    Takenaka T; Yamazaki K; Miura N; Mori R; Matsumoto R; Momosaki S; Takeo S
    Clin Lung Cancer; 2016 Mar; 17(2):e13-5. PubMed ID: 26704814
    [No Abstract]   [Full Text] [Related]  

  • 10. Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation.
    Kuo YW; Wu SG; Ho CC; Shih JY
    J Thorac Oncol; 2010 Dec; 5(12):2039-40. PubMed ID: 21102267
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literature.
    Siegele BJ; Shilo K; Chao BH; Carbone DP; Zhao W; Ioffe O; Franklin WA; Edelman MJ; Aisner DL
    Lung Cancer; 2016 May; 95():65-72. PubMed ID: 27040854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miliary never-smoking adenocarcinoma of the lung: strong association with epidermal growth factor receptor exon 19 deletion.
    Laack E; Simon R; Regier M; Andritzky B; Tennstedt P; Habermann C; Verth CZ; Thöm I; Grob T; Sauter G; Bokemeyer C
    J Thorac Oncol; 2011 Jan; 6(1):199-202. PubMed ID: 21178715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of EGFR mutations and EML4-ALK rearrangements in lung adenocarcinomas using archived cytological slides.
    Mitiushkina NV; Iyevleva AG; Poltoratskiy AN; Ivantsov AO; Togo AV; Polyakov IS; Orlov SV; Matsko DE; Novik VI; Imyanitov EN
    Cancer Cytopathol; 2013 Jul; 121(7):370-6. PubMed ID: 23408463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy.
    Ulivi P; Chiadini E; Dazzi C; Dubini A; Costantini M; Medri L; Puccetti M; Capelli L; Calistri D; Verlicchi A; Gamboni A; Papi M; Mariotti M; De Luigi N; Scarpi E; Bravaccini S; Turolla GM; Amadori D; Crinò L; Delmonte A
    Clin Lung Cancer; 2016 Sep; 17(5):384-390. PubMed ID: 26712101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of small biopsy specimens and surgical specimens for the detection of EGFR mutations and EML4-ALK in non-small-cell lung cancer.
    Xiao D; Lu C; Zhu W; He Q; Li Y; Fu C; Zhou J; Liu S; Tao Y
    Oncotarget; 2016 Sep; 7(37):59049-59057. PubMed ID: 27322143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel EML4-ALK variant: exon 6 of EML4 fused to exon 19 of ALK.
    Penzel R; Schirmacher P; Warth A
    J Thorac Oncol; 2012 Jul; 7(7):1198-9. PubMed ID: 22706607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.
    Takeuchi K; Choi YL; Soda M; Inamura K; Togashi Y; Hatano S; Enomoto M; Takada S; Yamashita Y; Satoh Y; Okumura S; Nakagawa K; Ishikawa Y; Mano H
    Clin Cancer Res; 2008 Oct; 14(20):6618-24. PubMed ID: 18927303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in molecular profile in NSCLC can be analyzed using cytological samples: development of EGFR resistance mutations and coexistence of ALK-EML4 translocation in an EGFR-sensitive patient.
    Lozano MD; Labiano T; Zudaire I; Subtil JC; Gúrpide A; Echeveste JI; Zulueta JJ; Martín-Algarra S; Pérez-Gracia JL
    Int J Surg Pathol; 2015 Apr; 23(2):111-5. PubMed ID: 24942894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Lung Adenocarcinoma Resistant to Crizotinib Harboring a Novel EML4-ALK Variant, Exon 6 of EML4 Fused to Exon 18 of ALK.
    Anai S; Takeshita M; Ando N; Ikematsu Y; Mishima S; Ishida K; Inoue K
    J Thorac Oncol; 2016 Oct; 11(10):e126-8. PubMed ID: 27663401
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.
    Kanaji N; Bandoh S; Ishii T; Tadokoro A; Watanabe N; Takahama T; Haba R; Imataki O; Dobashi H; Matsunaga T
    Lung Cancer; 2012 Aug; 77(2):293-8. PubMed ID: 22494566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.